Synthetic chemical in consumer products linked to early death, study saysOctober 12, 2021EndocrinologyPreventive CareAsthmaPediatricsMixed Topics
Age, C-reactive protein predict COVID-19 death in diabetesSeptember 29, 2021DiabetesCOVID-19 UpdatesEndocrinology
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinitionSeptember 20, 2021DiabetesCardiologyEndocrinology
A new weight loss threshold for T2d remission after bariatric surgery?September 20, 2021DiabetesObesityEndocrinologyCardiology
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEFSeptember 14, 2021DiabetesObesityCardiologyEndocrinology
At 18 months, much still unknown about diabetes and COVID-19September 13, 2021COVID-19 UpdatesDiabetesEndocrinology
FDA approves first once-weekly growth hormone for childrenSeptember 3, 2021EndocrinologyPediatricsRare Diseases
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEFAugust 31, 2021DiabetesCardiologyEndocrinology
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HFAugust 27, 2021DiabetesCardiologyEndocrinology
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthroughAugust 27, 2021DiabetesCardiologyEndocrinology
